BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.
Open | $0.67 |
Close | $0.58 |
Volume / Avg. | 1.01M / 629.18K |
Day Range | $0.58 - $0.67 |
52 Wk Range | 0.53 - 5.62 |
Market Cap | $21.97M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 2.39% |
Days to Cover | 1.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
Other companies in BioXcel Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX), Palatin Techs (AMEX:PTN) and Cue Biopharma (NASDAQ:CUE).
There is no analysis for BioXcel Therapeutics to provide a consensus price target.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $0.5855 last updated September 20, 2024 at 7:59 PM EDT.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.